Cite
MLA Citation
M Platten et al.. “OS6.4 NOA-16: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group evaluating a mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas.” Neuro-oncology, vol. 20, n.d., pp. iii226–iii227. http://access.bl.uk/ark:/81055/vdc_100095514174.0x000016